(3E)-3-[2-(3,4-Dichlorophenyl)hydrazin-1-ylidene]-1-(propan-2-yl)-2,3-dihydro-1H-indol-2-one

Catalog No. :
ACTCGW596
CAS No. :
320422-12-6
Molecular Formula :
C17H15Cl2N3O
Molecular Weight :
348.23

IUPAC Name:(E)-3-(2-(3,4-dichlorophenyl)hydrazineylidene)-1-isopropylindolin-2-one

(3E)-3-[2-(3,4-Dichlorophenyl)hydrazin-1-ylidene]-1-(propan-2-yl)-2,3-dihydro-1H-indol-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$558.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3E)-3-[2-(3,4-Dichlorophenyl)hydrazin-1-ylidene]-1-(propan-2-yl)-2,3-dihydro-1H-indol-2-one
IUPAC Name(E)-3-(2-(3,4-dichlorophenyl)hydrazineylidene)-1-isopropylindolin-2-one
MDL No.MFCD01314826
Molecular FormulaC17H15Cl2N3O
Molecular Weight348.23
SMILESCC(C)N1C(=O)/C(=N/NC2=CC=C(Cl)C(Cl)=C2)C2=C1C=CC=C2
InChI KeyGFSWIGNYERLCAF-LTGZKZEYSA-N
Synonym1-ISOPROPYL-1H-INDOLE-2,3-DIONE 3-[N-(3,4-DICHLOROPHENYL)HYDRAZONE];1H-Indole-2,3-dione, 1-(1-methylethyl)-, 3-[2-(3,4-dichlorophenyl)hydrazone]
CAS No.320422-12-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTCGW596 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGZSF721 route compound structure diagram
    ACGZSF72119763-90-7 In Stock
  4. Then
  5. ACTCGW596 route product structure diagram
    ACTCGW596320422-12-6
Inquiry

2. ACTCGW596 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTCGW596 route product structure diagram
    ACTCGW596320422-12-6
Inquiry

Comments (0)